Adherence and Subthreshold Adherence in Sleep Apnea Subjects Receiving Positive Airway Pressure Therapy: A Retrospective Study Evaluating Differences in Adherence Versus Use
Restricted accessResearch articleFirst published online August, 2016
Adherence and Subthreshold Adherence in Sleep Apnea Subjects Receiving Positive Airway Pressure Therapy: A Retrospective Study Evaluating Differences in Adherence Versus Use
Research on subthreshold compliance with positive airway pressure (PAP) therapy in sleep apnea patients may inform clinical sleep medicine practice. We retrospectively assessed compliant and subthreshold compliant sleep apnea subjects to test whether regular but fewer hours of PAP use would demonstrate clinically meaningful improvements and correlate with outcomes.
METHODS:
A chart review was conducted of 113 consecutive sleep apnea subjects, naive to treatment, who completed a titration study and filled a PAP therapy prescription. Objective data categorized subjects into 3 groups: compliant, subthreshold compliant, and minimal use. Outcome measures assessed changes in insomnia, sleepiness, and nocturia on average 7 months from PAP initiation. Correlation coefficients analyzed dose-response relationships between hours of use and changes in outcomes.
RESULTS:
Among 113 PAP attempters, 104 (92%) were current users. Among 93 users with objective data, regular (consistent) PAP users included 59 compliant and 21 subthreshold compliant, and 13 subjects were minimal users. Compliant users averaging 6.6 ± 1.3 h/night and 42.0 ± 12.1 h/week showed the largest outcome improvements (all P < .05) with moderate to large effects for insomnia (d = 0.94), sleepiness (d = 0.58), and nocturia (d = 0.56). Subthreshold users averaging 4.1 ± 0.7 h/night but only 18.0 ± 5.6 h/week showed a large effect for insomnia (d = 0.76, P = .03) and nonsignificant, small effects for sleepiness (d = 0.38) and nocturia (d = 0.22). Correlation coefficients showed a trend for decrease in insomnia (P = .08; r = .20) and a significant decrease in nocturia (P = .034; r = 0.25), each in association with hours of PAP use.
CONCLUSIONS:
In a clinical sample, 86% of sleep apnea subjects regularly used PAP, but adherence was 63%. Regular users showed clinical treatment effects and potential dose-response relationships, suggesting that the term use offers advantages over the term adherence. Currently, subthreshold compliance may not merit insurance coverage in many countries, an issue affecting many sleep apnea patients.
SchwabRJ, BadrSM, EpsteinLJ, GayPC, GozalD, KohlerM, et al. An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems: the optimal monitoring strategies and outcome measures in adults. Am J Respir Crit Care Med, 2013; 188(5):613–620.
2.
KribbsNB, PackAI, KlineLR, SmithPL, SchwartzAR, SchubertNM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis, 1993; 147(4):887–895.
3.
AyasN, SkomroR, BlackmanA, CurrenK, FitzpatrickM, FleethamJ, et al. Obstructive sleep apnea and driving: a Canadian Thoracic Society and Canadian Sleep Society position paper. Can Respir J, 2014; 21(2):114–123.
European Sleep and Diagnostics Reimbursement Overview. ResMed, 2015. Correspondence from ResMed.
6.
Reeves-HocheMK, MeckR, ZwillichCW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med, 1994; 149(1):149–154.
7.
SalepciB, CaglayanB, KiralN, ParmaksizET, ComertSS, SaracG, et al. CPAP adherence of patients with obstructive sleep apnea. Respir Care, 2013; 58(9):1467–1473.
8.
WeaverTE, GrunsteinRR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc, 2008; 5(2):173–178.
9.
SackettDL, StrausSE, RichardsonWS, RosenbergW, HaynesRB. Evidence-based medicine: how to practice and teach EBM. 2nd edition. Edinburgh, Scotland: Churchhill Livingstone; 2000:173–177.
BorelJC, TamisierR, Dias-DomingosS, SapeneM, MartinF, StachB, et al. Type of mask may impact on continuous positive airway pressure adherence in apneic patients. PLoS One, 2013; 8(5):e64382.
14.
WeaverTE, KribbsNB, PackAI, KlineLR, ChughDK, MaislinG, et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep, 1997; 20(4):278–283.
15.
WildMR, EnglemanHM, DouglasNJ, EspieCA. Can psychological factors help us to determine adherence to CPAP? A prospective study. Eur Respir J, 2004; 24(3):461–465.
16.
BroströmA, NilsenP, JohanssonP, UlanderM, StrömbergA, SvanborgE, FridlundB. Putative facilitators and barriers for adherence to CPAP treatment in patients with obstructive sleep apnea syndrome: a qualitative content analysis. Sleep Med, 2010; 11(2):126–130.
17.
BolligSM. Encouraging CPAP adherence: it is everyone's job. Respir Care, 2010; 55(9):1230–1239.
18.
KingshottRN, VennelleM, HoyCJ, EnglemanHM, DearyIJ, DouglasNJ. Predictors of improvements in daytime function outcomes with CPAP therapy. Am J Respir Crit Care Med, 2000; 161(3 Pt 1):866–871.
19.
StradlingJR, DaviesRJ. Is more NCPAP better?. Sleep, 2000; 23(Suppl 4):S150–S153.
20.
FaccendaJF, MackayTW, BoonNA, DouglasNJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med, 2001; 163(2):344–348.
21.
WeaverTE, MaislinG, DingesDF, BloxhamT, GeorgeCF, GreenbergH, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep, 2007; 30(6):711–719.
22.
AnticNA, CatchesideP, BuchanC, HensleyM, NaughtonMT, RowlandS, et al. The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep, 2011; 34(1):111–119.
23.
EnglemanHM, MartinSE, DearyIJ, DouglasNJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet, 1994; 343(8897):572–575.
24.
Martinez-GarciaMA, Soler-CatalunaJJ, Ejarque-MartinezL, SorianoY, Roman-SanchezP, IllaFB, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med, 2009; 180(1):36–41.
25.
McDaidC, GriffinS, WeatherlyH, DureeK, van derBM, van HoutS, et al. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assess, 2009; 13(4):iii–iv, xi–xiv, 1–119.
26.
PekerY, HednerJ, JohanssonA, BendeM. Reduced hospitalization with cardiovascular and pulmonary disease in obstructive sleep apnea patients on nasal CPAP treatment. Sleep, 1997; 20(8):645–653.
27.
StepnowskyCJJr, MoorePJ. Nasal CPAP treatment for obstructive sleep apnea: developing a new perspective on dosing strategies and compliance. J Psychosom Res, 2003; 54(6):599–605.
28.
Campos-RodriguezF, Peña-GriñanN, Reyes-NuñezN, De la Cruz-MoronI, Perez-RonchelJ, De la Vega-GallardoF, Fernandez-PalacinA. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest, 2005; 128(2):624–633.
29.
EnglemanHM, CheshireKE, DearyIJ, DouglasNJ. Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax, 1993; 48(9):911–914.
30.
EnglemanHM, KingshottRN, WraithPK, MackayTW, DearyIJ, DouglasNJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med, 1999; 159(2):461–467.
31.
JenkinsonC, DaviesRJ, MullinsR, StradlingJR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet, 1999; 353(9170):2100–2105.
32.
RedlineS, AdamsN, StraussME, RoebuckT, WintersM, RosenbergC. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med, 1998; 157(3 Pt 1):858–865.
33.
ZimmermanME, ArnedtJT, StanchinaM, MillmanRP, AloiaMS. Normalization of memory performance and positive airway pressure adherence in memory-impaired patients with obstructive sleep apnea. Chest, 2006; 130(6):1772–1778.
34.
AloiaMS, KnoepkeCE, Lee-ChiongT. The new local coverage determination criteria for adherence to positive airway pressure treatment: testing the limits?. Chest, 2010; 138(4):875–879.
35.
WickwireEM, LettieriCJ, CairnsAA, CollopNA. Maximizing positive airway pressure adherence in adults: a common-sense approach. Chest, 2013; 144(2):680–693.
36.
BrownLK. Use it or lose it: Medicare's new paradigm for durable medical equipment coverage?. Chest, 2010; 138(4):785–789.
37.
RomeroE, KrakowB, HaynesP, UlibarriV. Nocturia and snoring: predictive symptoms for obstructive sleep apnea. Sleep Breath, 2010; 14(4):337–343.
38.
KrakowB, UlibarriVA, RomeroEA, McIverND. A two-year prospective study on the frequency and co-occurrence of insomnia and sleep-disordered breathing symptoms in a primary care population. Sleep Med, 2013; 14(9):814–823.
39.
FitzgeraldMP, MulliganM, ParthasarathyS. Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. Am J Obstet Gynecol, 2006; 194(5):1399–1403.
40.
BliwiseDL, FriedmanL, HernandezB, ZeitzerJM, KushidaCA, YesavageJA. Nocturia reported in nightly sleep diaries: common occurrence with significant implications?. Health Psychol, 2014; 33(11):1362–1365.
41.
KrakowB, MelendrezD, FerreiraE, ClarkJ, WarnerTD, SisleyB, SklarD. Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest, 2001; 120(6):1923–1929.
42.
SmithS, SullivanK, HopkinsW, DouglasJ. Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Sleep Med, 2004; 5(5):449–456.
43.
WickwireEM, CollopNA. Insomnia and sleep-related breathing disorders. Chest, 2010; 137(6):1449–1463.
44.
American Academy of Sleep Medicine. The International classification of sleep disorders: diagnostic and coding manual. 2nd edition. Westchester, Illinois: American Academy of Sleep Medicine. 2005:51–55.
45.
BastienCH, VallièresA, MorinCM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med, 2001; 2(4):297–307.
46.
JohnsMW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 1991; 14(6):540–545.
47.
BerryRB, BudhirajaR, GottliebDJ, GozalD, IberC, KapurVK, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events: deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med, 2012; 8(5):597–619.
48.
KushidaCA, LittnerMR, HirshkowitzM, MorgenthalerTI, AlessiCA, BaileyD, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep, 2006; 29(3):375–380.
49.
FalconeVA, DamianiMF, QuarantaVN, CapozzoloA, RestaO. Polysomnograph chart view by patients: a new educational strategy to improve CPAP adherence in sleep apnea therapy. Respir Care, 2014; 59(2):193–198.
50.
NadeemR, RishiMA, SrinivasanL, CopurAS, NaseemJ. Effect of visualization of raw graphic polysomnography data by sleep apnea patients on adherence to CPAP therapy. Respir Care, 2013; 58(4):607–613.
51.
PatelN, SamA, ValentinA, QuanSF, ParthasarathyS. Refill rates of accessories for positive airway pressure therapy as a surrogate measure of long-term adherence. J Clin Sleep Med, 2012; 8(2):169–175.
52.
AsghariA, MohammadiF, KamravaSK, TavakoliS, FarhadiM. Severity of depression and anxiety in obstructive sleep apnea syndrome. Eur Arch Otorhinolaryngol, 2012; 269(12):2549–2553.
53.
BabsonKA, Del ReAC, Bonn-MillerMO, WoodwardSH. The comorbidity of sleep apnea and mood, anxiety, and substance use disorders among obese military veterans within the Veterans Health Administration. J Clin Sleep Med, 2013; 9(12):1253–1258.
54.
BjörnsdóttirE, BenediktsdóttirB, PackAI, ArnardottirES, KunaST, GíslasonT, et al. The prevalence of depression among untreated obstructive sleep apnea patients using a standardized psychiatric interview. J Clin Sleep Med, 2016; 12(1):105–112.
55.
HarrisM, GlozierN, RatnavadivelR, GrunsteinRR. Obstructive sleep apnea and depression. Sleep Med Rev, 2009; 13(6):437–444.
56.
LeeK, BaronK, SocaR, AttarianH. The prevalence and characteristics of REM sleep without atonia (RSWA) in patients taking antidepressants. J Clin Sleep Med, 2015 [Epub ahead of print].
57.
SharafkhanehA, GirayN, RichardsonP, YoungT, HirshkowitzM. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep, 2005; 28(11):1405–1411.
58.
BroströmA, StrömbergA, MårtenssonJ, UlanderM, HarderL, SvanborgE. Association of Type D personality to perceived side effects and adherence in CPAP-treated patients with OSAS. J Sleep Res, 2007; 16(4):439–447.
59.
DunnRL, DonoghueJM, OzminkowskiRJ, StephensonD, HylanTR. Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines. J Psychopharmacol, 1999; 13(2):136–143.
60.
McFadyenTA, EspieCA, McArdleN, DouglasNJ, EnglemanHM. Controlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy. Eur Respir J, 2001; 18(6):996–1002.
